BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30772444)

  • 1. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
    Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
    J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.
    Innos K; Horn-Ross PL
    Cancer; 2003 Feb; 97(4):1099-106. PubMed ID: 12569612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Ductal Carcinoma
    Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Mammography Screening: Does Age Influence the Detection Rates of Low-, Intermediate-, and High-Grade Ductal Carcinoma in Situ?
    Weigel S; Hense HW; Heidrich J; Berkemeyer S; Heindel W; Heidinger O
    Radiology; 2016 Mar; 278(3):707-13. PubMed ID: 26505802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non-Hispanic white women in New Mexico, 1973-1994.
    Adams-Cameron M; Gilliland FD; Hunt WC; Key CR
    Cancer; 1999 Mar; 85(5):1084-90. PubMed ID: 10091792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.
    Hou N; Huo D
    Breast Cancer Res Treat; 2013 Apr; 138(2):633-41. PubMed ID: 23446808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.
    Ernster VL; Barclay J
    J Natl Cancer Inst Monogr; 1997; (22):151-6. PubMed ID: 9709292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in breast cancer by race and ethnicity: update 2006.
    Smigal C; Jemal A; Ward E; Cokkinides V; Smith R; Howe HL; Thun M
    CA Cancer J Clin; 2006; 56(3):168-83. PubMed ID: 16737949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium.
    Allison KH; Abraham LA; Weaver DL; Tosteson AN; Nelson HD; Onega T; Geller BM; Kerlikowske K; Carney PA; Ichikawa LE; Buist DS; Elmore JG
    Cancer; 2015 May; 121(9):1369-78. PubMed ID: 25603785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use.
    Farhat GN; Walker R; Buist DS; Onega T; Kerlikowske K
    J Clin Oncol; 2010 Dec; 28(35):5140-6. PubMed ID: 21060026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ breast cancer: incidence trend and organised screening programmes in Italy.
    Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
    Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.
    Ernster VL; Barclay J; Kerlikowske K; Wilkie H; Ballard-Barbash R
    Arch Intern Med; 2000 Apr; 160(7):953-8. PubMed ID: 10761960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter- and intra-ethnic differences for female breast carcinoma incidence in the continental United States and in the state of Hawaii.
    Fong M; Henson DE; Devesa SS; Anderson WF
    Breast Cancer Res Treat; 2006 May; 97(1):57-65. PubMed ID: 16322891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
    Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
    JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of ductal carcinoma in situ.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 2010; 2010(41):139-41. PubMed ID: 20956818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.